SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation today announced that Stanford University has used the unique properties of the company’s integrated fluidic circuits (IFCs) to help develop a noninvasive prenatal test for fetal chromosomal abnormalities using maternal blood.
